![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PHILIPS AND BG MEDICINE FORM ALLIANCE FOR MOLECULAR MEDICINE RESEARCH AND DEVELOPMENT
PHILIPS AND BG MEDICINE FORM ALLIANCE FOR MOLECULAR MEDICINE RESEARCH AND DEVELOPMENT
August 14, 2006
Royal Philips Electronics and BGMedicine have established an alliance in the field of Systems Biology. Under the partnership agreement BG Medicine will collaborate withPhilips to develop the next generation of molecular healthcareproducts for
application in areas such as molecular imaging andpoint-of-care diagnostics.
Key to the alliance is BGM's proprietarysystems profiling technologies that
identify biomarker sets associatedwith disease stage, progression and treatment.
BG Medicine has grantedPhilips preferential access to certain of its proprietary
technologiesand services, and Philips has acquired a minority stake in BGMedicine,
which is privately-held and based in Waltham, Massachusetts.
Finanzen.net
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct